C&D NEWIN (00731) announces its annual performance with a shareholders' loss of 73.66 million Hong Kong dollars, a turnaround from a profit to a loss compared to the previous year.
Jianfa Xinsong (00731) announced its annual performance for the year ending December 31, 2025. The group achieved a profit of HK$1.459 billion, an increase of 9.6% year-on-year. The company's owners suffered a loss of HK$73.661 million for the year, a reversal from profit to loss compared to the previous year. This translates to a loss per share of 5.2 HK cents.
C&D NEWIN (00731) announced its annual performance for the year ending December 31, 2025. The group achieved a profit of HK$1.459 billion, a year-on-year increase of 9.6%. The company's attributable loss for the year was HK$73.661 million, a year-on-year change from profit to loss. The loss per share was HK$0.052.
The announcement stated that the increase in profit was mainly due to the revenue of approximately HK$129 million from the trading division in the current year.
Related Articles

CHINA INFO TECH (08178) announced its annual performance, with a net loss attributable to shareholders of HK$99.459 million for the year, representing a 164.28% increase compared to the previous year.

BRIGHTSTAR TECH (08446) announces its annual performance for 2025, with a net profit attributable to shareholders of HK$25,949,000, a decrease of 38.7% compared to the previous year.

Ming Liang Holdings (08152) announced its 2025 performance, with a profit attributable to equity holders of HK$9.426 million, turning losses into profits year on year.
CHINA INFO TECH (08178) announced its annual performance, with a net loss attributable to shareholders of HK$99.459 million for the year, representing a 164.28% increase compared to the previous year.

BRIGHTSTAR TECH (08446) announces its annual performance for 2025, with a net profit attributable to shareholders of HK$25,949,000, a decrease of 38.7% compared to the previous year.

Ming Liang Holdings (08152) announced its 2025 performance, with a profit attributable to equity holders of HK$9.426 million, turning losses into profits year on year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


